Institutional investments, especially those disclosed in 13D filings, often indicate a high level of confidence in a company's future prospects. Shah Capital Management's significant stake in Novavax could be perceived positively by the market, leading to increased investor interest and potentially driving up the stock price in the short term. The 6.66% stake is substantial enough to suggest that Shah Capital sees significant value in Novavax, which might encourage other investors to follow suit.